67
51
Growth Score 67 in past quarter
-11 pts
Heat Score 51 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
304224
Okava Pharmaceuticals is a Clinical stage biotechnology company.
- Michael Klotsman: Founder & CEO
About the Company
Okava’s goal is to capitalize on the highly under-developed, but rapidly growing veterinary pharmaceutical market, by repurposing validated human medicines using mature drug delivery technologies.
This R&D approach offers an inexpensive and risk-mitigated approach for tapping into a large, high-growth market.
